Moreover, Deben et al25 recently showed that the Pro allele of the TP53 R72P polymorphism was predictive of worse OS in stage I NSCLC and that the R213R polymorphism was significantly associated with TP53 mutations in patients with NSCLC ADC. The gene discussed is TP53; the disease is non-small cell lung carcinoma.